Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015322 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Dexfenfluramine |
---|
Description | Dexfenfluramine, also known as redux, belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. Dexfenfluramine is a drug which is used for the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet. Dexfenfluramine is a very strong basic compound (based on its pKa). Dexfenfluramine is a potentially toxic compound. The S-enantiomer of fenfluramine. It stimulates the release of serotonin and selectively inhibits its reuptake, but unlike fenfluramine it does not possess catecholamine agonist activity. It was formerly given by mouth as the hydrochloride in the treatment of obesity, but, like fenfluramine, was withdrawn wolrdwide following reports of valvular heart defects. |
---|
Structure | CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-Fenfluramine | ChEBI | (S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine | ChEBI | D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine | ChEBI | Dexfenfluramina | ChEBI | Dexfenfluraminum | ChEBI | Dextrofenfluramine | ChEBI | D-N-Ethyl-a-methyl-m-trifluoromethylphenethylamine | Generator | D-N-Ethyl-α-methyl-m-trifluoromethylphenethylamine | Generator | (S)-Fenfluramine | HMDB | Dexfenfluramine hydrochloride | HMDB | Redux | HMDB | Wyeth brand OF dexfenfluramine hydrochloride | HMDB | Hydrochloride, dexfenfluramine | HMDB | Dexfenfluramine | ChEBI |
|
---|
Chemical Formula | C12H16F3N |
---|
Average Molecular Weight | 231.2573 |
---|
Monoisotopic Molecular Weight | 231.123484132 |
---|
IUPAC Name | ethyl[(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-yl]amine |
---|
Traditional Name | dexfenfluramine |
---|
CAS Registry Number | 3239-44-9 |
---|
SMILES | CCN[C@@H](C)CC1=CC=CC(=C1)C(F)(F)F |
---|
InChI Identifier | InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1 |
---|
InChI Key | DBGIVFWFUFKIQN-VIFPVBQESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenethylamines |
---|
Direct Parent | Amphetamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Amphetamine or derivatives
- Trifluoromethylbenzene
- Phenylpropane
- Aralkylamine
- Secondary aliphatic amine
- Secondary amine
- Alkyl fluoride
- Hydrocarbon derivative
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Alkyl halide
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.022 g/L | Not Available | LogP | 3.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Dexfenfluramine,1TMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C | 1472.6 | Semi standard non polar | 33892256 | Dexfenfluramine,1TMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C | 1532.8 | Standard non polar | 33892256 | Dexfenfluramine,1TMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C | 1476.0 | Standard polar | 33892256 | Dexfenfluramine,1TBDMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C(C)(C)C | 1698.3 | Semi standard non polar | 33892256 | Dexfenfluramine,1TBDMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C(C)(C)C | 1731.4 | Standard non polar | 33892256 | Dexfenfluramine,1TBDMS,isomer #1 | CCN([C@@H](C)CC1=CC=CC(C(F)(F)F)=C1)[Si](C)(C)C(C)(C)C | 1618.0 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Dexfenfluramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-9110000000-1bb444f1022b28d94dc0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dexfenfluramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dexfenfluramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 10V, Positive-QTOF | splash10-001i-1190000000-7fbe4443e51aea6826c3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 20V, Positive-QTOF | splash10-001r-8890000000-5cd73b17e1103d99e7fb | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 40V, Positive-QTOF | splash10-00ov-9610000000-58d820854fe8992bc6a3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 10V, Negative-QTOF | splash10-001i-0090000000-96055c6c721aecfc76f8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 20V, Negative-QTOF | splash10-001i-2190000000-2f8c88fb4bc53943412f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 40V, Negative-QTOF | splash10-0006-9410000000-a342d0ae14c5230c00a4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 10V, Positive-QTOF | splash10-001i-0290000000-ac3db862ce9c06ed67f5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 20V, Positive-QTOF | splash10-0a4i-0910000000-6cb4ba049f7be32b0f1c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 40V, Positive-QTOF | splash10-0a4i-1900000000-43131e1ffc852067efa9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 10V, Negative-QTOF | splash10-001i-0090000000-8ae4a9b01f14913328e8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 20V, Negative-QTOF | splash10-0a5i-0930000000-c301feb5a0d5278285b2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexfenfluramine 40V, Negative-QTOF | splash10-0a4i-0900000000-30767724225603e597e1 | 2021-10-11 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01191 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01191 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01191 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 59646 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Dexfenfluramine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 66265 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 439329 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Kalia M: Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons. Brain Res. 1991 May 10;548(1-2):111-25. [PubMed:1868326 ]
|
---|